X-linked Retinoschisis
📧 Sign up to get email alerts when something new happens for X-linked Retinoschisis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients [EARLY_Phase 1]
A Phase 1 safety and efficacy trial of the gene therapy ZM-01 for X-linked retinoschisis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis [Phase 1, Phase 2]
Atsena Therapeutics reports ATSN-201 gene therapy for RS1-associated X-linked retinoschisis is in Phase 1/Phase 2 and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis [Phase 1, Phase 2]
A Phase 1/2 ocular gene transfer study for X-linked retinoschisis (RS1) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS) [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of rAAV-hRS1 for X-linked Retinoschisis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Clinical Evaluation of Patients With X-linked Retinoschisis
Completed clinical trial evaluating patients with X-linked retinoschisis, sponsored by Beacon Therapeutics.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.